Literature DB >> 18449408

Therapeutic integrin inhibition: allosteric and activation-specific inhibition strategies may surpass the initial ligand-mimetic strategies.

Ingo Ahrens, Karlheinz Peter.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18449408     DOI: 10.1160/TH08-03-0194

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  3 in total

Review 1.  Integrins as therapeutic targets: lessons and opportunities.

Authors:  Dermot Cox; Marian Brennan; Niamh Moran
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

2.  Anti-αLβ2 antibodies reveal novel endocytotic cross-modulatory functionality.

Authors:  Riccardo V Mancuso; Jens Casper; Albrecht G Schmidt; Stephan Krähenbühl; Gabriele Weitz-Schmidt
Journal:  Br J Pharmacol       Date:  2020-03-09       Impact factor: 8.739

Review 3.  Current Strategies for Microbubble-Based Thrombus Targeting: Activation-Specific Epitopes and Small Molecular Ligands.

Authors:  Zhaojian Wang; Huaigu Huang; Yuexin Chen; Yuehong Zheng
Journal:  Front Bioeng Biotechnol       Date:  2021-07-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.